locus is assigned to the telomeric region of chromosome 8p by linkage. Analyses of recombinations place the locus in the 7-centimorgan interval between AFM185xb2 and D8S262 in which three markers, D8S504, D8S264, and AFMO77yg5, show no recombinations with the phenotype. Haplotypes comprising alleles at the above five loci support the hypothesis of a single founding mutation for all affected chromosomes except the one belonging to the unrelated parent, who has a very different haplotype, suggesting another mutation or a very old ancestry of a single mutation. This study raises to three the number of heritable epilepsies whose gene loci have been mapped and provides a starting point for the cloning of the gene. It also suggests the possibility that the disease might not be limited to the northern Finnish population.
Epilepsy occurs in =3% of the population (1), either as an isolated symptom or as a part of disease phenotypes with a Mendelian or non-Mendelian inheritance (2) . Despite intensive worldwide efforts to elucidate the etiology and pathogenesis of idiopathic epilepsy, progress has been limited and slow.
One way of approaching the pathology of epilepsy is to focus on well-delineated disease entities in which epilepsy is the main or primary, as opposed to a minor or secondary, feature of the phenotype. Several such syndromes exist, many of which show undisputable heredity (3) . It is potentially important to identify the genes whose mutations cause these disorders. However, to date, the genes of only two epilepsies with clear-cut Mendelian inheritance have been mapped-namely, two loci for benign familial neonatal convulsions (4, 5) and one for progressive myoclonic epilepsy of Unverricht-Lundborg type (6)-but none of these genes has been cloned. A third epilepsy, juvenile myoclonus epilepsy, is probably clinically and genetically heterogeneous, as shown by inconsistent and contradictory linkage results (7) (8) (9) tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Markers. All markers were (CA),-repeat polymorphisms from the Genethon collection (11, 12) . For the initial screening a set ofmarkers located -40 centimorgans (cM) apart was utilized, followed by another set filling each 40-cM gap with one to three markers. Whenever possible, three to five, carefully chosen markers were co-amplified in a 10-t4 reaction volume using published protocols (13) .
Linkage and Linkage DisequiMbrium Analysis. Linkage analyses were performed by computer programs of the LINK-AGE program package (14) . All results were obtained assuming complete penetrance. The simulation program SLINK (15, 16) was used to define a minimum number of studied individuals in the initial screening. For multipoint analysis marker genotypes were reduced to three-allele loci. The analysis (LINKMAP) based on the given fixed order telomereAFM185xb2-D8S504-D8S264-AFMO77ygS-D8S262-centromere and fixed sex-average recombination fractions (0.01, 0.01, 0.03, 0.02 cM) between the five marker loci (12 Linkage disequilibrium was readily apparent to alleles of markers AFM185xb2 (P < 0.001), D8S264 (P < 0.01), and D85262 (P < 0.01) ( Table 2 ). Markers D8S504 andAFMO77ygS showed the same allele in the majority of the disease chromosomes, but as that allele was also the most common one in the normal chromosomes a possible linkage disequilibrium was not statistically significant. Haplotypes around the disease locus were constructed using the allele data of all five markers studied (Table 3) . Of 16 disease-associated haplotypes, 13 were identical and none occurred on any of the 18 normal chromosomes studied. Two disease haplotypes deviated only little from the main one. However, one was very different and, interestingly, this haplotype belonged to the (10) as well as the two loci for benign neonatal convulsions in chromosomes 20q and 8q (4, 5) as candidate loci for EPMR. Our data confirm the recessive type of inheritance of EPMR suggested by previous pedigree studies (10) . The patients chosen for the study were clinically homogeneous with little intra-and interfamilial variation. As they also shared one or two ancestral couples, the absence of linkage heterogeneity and the finding of marked linkage disequilibrium were not surprising. Our findings amply confirm the validity ofthe established diagnostic criteria (10) and the specific identity of this epilepsy syndrome.
By constructing haplotypes of loci closely linked to the disease locus the presumptive ancestral haplotype can be deduced. Individuals in whom a disease chromosome shows deviations from this haplotype may provide information comparable to recombinations that one can observe in larger study populations. In our series of 16 disease chromosomes, 13 had the ancestral haplotype 2-1-3-2-4 that did not occur in any of the 18 normal chromosomes studied. Two other haplotypes, 2-4-3-2-4 and 4-1-3-1-4, differed somewhat from the ancestral haplotype. If the changes represent ancestral crossovers rather than new mutations of the marker loci, then the region proximal of the fourth marker and distal of the second marker can be excluded as the site of the mutation. This would limit the region of EPMR to between D8S504 and AFMO77ygS, and EPMR would thus lie very close to locus D8S264, the only locus having the same allele in all disease chromosomes except the one discussed below.
Interestingly, one disease chromosome had the haplotype 4-4-11-2-1 that is very different from the ancestral one and that was also not seen in any of the normal control chromosomes. As this chromosome occurred in the only parent who could not be genealogically linked to the founding ancestral couples it lends itself to two alternative explanations. First, the different haplotype might indicate a mutation different (23) , that has been localized physically to 8p23.1-p22 (24) . Another interesting gene is the a2 subunit of neuronal nicotinic cholinergic receptor that has been localized to chromosome 8, but whose more precise localization is not known (25) . The role of these two and other potential candidate genes can be tested in our patients. If this approach is not successful in defining the EPMR gene, positional cloning is now easier than before thanks to improved tools such as yeast artificial chromosomes that have already been defined for this region (26) .
Our results provide a basis for one immediate application: presymptomatic or prenatal testing can now be offered to Finnish families with at least one child affected with EPMR. Given the existence of several highly polymorphic markers showing no recombinations in Finnish families, these predictions should be highly accurate.
As a conclusion, EPMR is a progressive inherited disorder affecting the central nervous system and caused by a gene in distal 8p, whose pathogenesis is still unknown. It is one of a few conditions that are rare, show a Mendelian inheritance pattern, have epilepsy as their main manifestation, and only affect the central nervous system. In a longer perspective, the characterization of such genes may help in understanding the pathophysiology of epilepsy in general.
